FATE THERAPEUTICS INC (FATE) Executive Compensation
FATE THERAPEUTICS INC (FATE) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FATE
CIK: 1434316
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerRachael Marini
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001193125-26-403429 | View SEC Doc Filr Page |
| S-8 | 2026-08-13 | — | S-8 | 0001193125-26-349151 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-347988 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347984 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 | 0001193125-26-335019 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 | 0001193125-26-335007 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001959173-26-005627 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001959173-26-005625 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0002012383-26-001939 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074130 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | OWNERSHIP DOCUMENT | 0001104659-26-074126 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271090 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271088 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271083 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271079 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271074 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271072 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271069 | View SEC Doc Filr Page |
| 3 | 2026-06-15 | 2026-06-12 | 3 | 0001193125-26-271062 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-12 | 8-K | 0001193125-26-271055 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | 8-K | 0001193125-26-257558 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | 4 | 0001193125-26-234390 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | 4 | 0001193125-26-234380 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001959173-26-003833 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001959173-26-003832 | View SEC Doc Filr Page |